1. Transpharmation Enhances Global Talent Acquisition with Cykel AI Partnership
2. Transpharmation Ltd. Announces Strategic Acquisition of Saretius Ltd.
3. Society for Neuroscience 2024
4. Neuropsychiatric Drug Development Summit
5. Safety Pharmacology Society (SPS)
6. ILAE - 15th European Epilepsy congress
7. Kansas City Animal Health Corridor
8. IASP 2024 World Congress on Pain
9. AAIC 2024
10. OARSI 2024
11. Western Veterinary Conference
12. AD/PD 2024
13. Animal Health, Nutrition & Technology Innovation
14. VMX 2024
15. American College of Toxicology
16. Society for Neuroscience 2023
17. CNS Summit
18. Canine Conference 2023
19. Animal Health, Nutrition & Technology Innovation - Asia
20. ELRIG Drug Discovery
21. BioJapan 2023
22. 2023 SPS Annual Meeting
23. Breaking New Ground: Unleashing Canine EEG Capabilities for Enhanced Research at Transpharmation Canada.
24. The 6th Animal Health, Nutrition and Technology Innovation Meeting
25. NeuPSIG 2023
26. International League Against Epilepsy
27. The 2023 Animal Health Summit
28. Best Poster Winner!
29. Alzheimer's Association International Conference
30. Transpharmation Collaborates With Artelo Biosciences To Support Development Of Neuropathic Pain Treatment
31. 12th European Zebrafish Meeting
32. Transpharmation and Veterinary Health Research Centers Partnership
33. Published!
34. The Neuro4D Conference
35. Psychedelic Therapeutics and Drug Development Conference
36. New poster added to our publications page, recently presented at FENS
37. New poster added to our publications page, recently presented at ADPD!
38. FENS Regional Meeting 2023
39. Neuroimmunology Drug Development Summit
40. New clients, different time zones
41. AD/PD 2023
42. OARSI World Congress
43. Veterinary Meeting and Expo
44. Dr. Pabitra H. Patra paper published in PAIN
45. New published work!
46. Name change announcement, news from the CEO
47. Society for Neuroscience 2022, November 12-16, California
48. CNS Therapeutic Xchange Europe 2022, Zurich - 24th November
49. ECNP Congress, 15th-18th October - Vienna, Austria
50. Here, there and everywhere - we love meeting up with you!
51. Recent collaborative work published by Frontiers in Molecular Neuroscience
52. Global representation meeting the needs of our worldwide client base
53. Animals in scientific research, 7th Annual Conference, by PolLASA. 12-14th September, Warsaw, Poland
54. The Safety Pharmacology Society Annual Meeting - September 11-14, Montréal, Canada
55. HubXchange's US West Coast CNS Therapeutics Meeting - 29th September
56. IASP World Conference on Pain - Toronto, Canada, 19th - 23rd September
57. Rapid access to canine preclinical studies and leading PK expertise
58. Collaboration between Zebrafish Lab and Transpharmation continues
59. 5th Polish Zebrafish Society Workshop in Lublin (Poland) 29th June - 1st July
60. Progressive Ratio Task reveals effectiveness of single-dose psilocybin
61. BPS live! Rapid acting antidepressants, from ketamine to psychedelics TUESDAY 10TH, 17TH AND 24TH MAY, 2PM (BST)
62. The Neuro4D Conference 2022, Mainz, Germany, 16th - 17th May 2022
63. SMi’s 22nd Annual Conference; Pain Therapeutics, 4 - 5 May, 2022, London
64. Long term and delayed effects of psychedelics in preclinical models
65. ADPD, 16th International Conference on Alzheimer's Disease and Parkinson's Disease – 15 - 20 March 2022
66. Transpharmation’s Facilities Management Company receive AAALAC accreditation
67. Fierce Biotech report on Transpharmation and InterVivo's joint venture
68. InterVivo Solutions and Transpharmation join forces as sister companies
69. Zebrafish as a translational model for neuroscience research
70. HubXchange - CNS Therapeutics Xchange Europe 2021 – 2nd December 2021
71. The Society for Neuroscience 50th Annual Meeting will be fully virtual - 8-11 November
72. 34th ECNP Congress Hybrid - Lisbon, Portugal - 2nd - 5th October 2021
73. Neurex Neuroforum 2021
74. Cannabinoids and Psychedelics; Neuroscience Ireland Meeting 2021 - 9th-10th September 2021
75. UK scientists at Transpharmation and Clerkenwell Health combine lab and human trials, as psilocybin offers hope for people with an end-of-life diagnosis
76. FENS Regional Meeting (FRM) - 25-27 August 2021
77. InterVivo Solutions Provides Update on Cooperative Psychedelics Evaluation Platform (COPE)
78. 31st Annual International Cannabinoid Research Society (ICRS) Virtual Symposium on Cannabinoids - 21-24 June 2021
79. Transpharmation Ireland gains Green Labs certification
80. Let us inspire you!
81. Transpharmation’s pain expertise recognised
82. HubXchange's US East Coast CNS Therapeutics e-Xchange Virtual meeting - 24-26 May 2021
83. SMi - 21st Annual Conference Pain Therapeutics Virtual conference - 10-11 of May 2021
84. ICNMD – 16th International Congress on Neuromuscular Diseases Digital 2021 - 21-22 & 28-29 May 2021
85. BNA 2021 - British Neuroscience Association - Festival of Neuroscience 2021 Virtual Conference 12-15 April 2021
86. 3rd Annual Neuroimmunology Drug Development Summit 2021 Virtual Conference – 27-29 April 2021
87. “Companies have no borders”, said Mark Duxon, CEO of Transpharmation
88. ADPD, 15th International Conference on Alzheimer's Disease and Parkinson's Disease – 9-14 March 2021
89. New Laboratory
90. InterVivo Solutions Issued Institutional Cannabis Research License By Health Canada
91. ASENT - American Society of Experimental Neurotherapeutics 2021 Virtual Conference 22-25 of February 2021
92. Peer Review Journal Publication
93. Society for Neuroscience (SfN) digital event 11-13th January 2021
94. Neuronus 2020 IBRO neuroscience forum - 8th - 11th December 2020
95. Transpharmation’s expansion to world class facilities!
96. Young Investigator Symposium, 6th November 2020
97. Inflammasome Therapeutics Summit - 4th - 6th November 2020
98. Ten year anniversary!
99. WMS virtual conference - 28th September – 2nd October 2020
100. Alzheimer’s Drug Discovery Foundation (ADDF) - 5th and 6th October 2020